Literature DB >> 4117197

Bilateral adrenalectomy for palliative treatment of prostatic cancer.

E M Mahoney, J H Harrison.   

Abstract

Entities:  

Mesh：

Year:  1972        PMID： 4117197     DOI： 10.1016/s0022-5347(17)60911-x

Source DB:  PubMed          Journal:  J Urol        ISSN： 0022-5347            Impact factor:   7.450


× No keyword cloud information.
  7 in total

1.  Phase II study of androgen synthesis inhibition with ketoconazole, hydrocortisone, and dutasteride in asymptomatic castration-resistant prostate cancer.

Authors:  Mary-Ellen Taplin; Meredith M Regan; Yoo-Joung Ko; Glenn J Bubley; Stephen E Duggan; Lillian Werner; Tomasz M Beer; Christopher W Ryan; Paul Mathew; Shi-Ming Tu; Samuel R Denmeade; William K Oh; Oliver Sartor; Christos S Mantzoros; Roger Rittmaster; Philip W Kantoff; Steven P Balk
Journal:  Clin Cancer Res       Date:  2009-11-03       Impact factor: 12.531

2.  Treatment of advanced prostatic carcinoma.

Authors: 
Journal:  Br Med J       Date:  1979-09-29

3.  Intratumoral de novo steroid synthesis activates androgen receptor in castration-resistant prostate cancer and is upregulated by treatment with CYP17A1 inhibitors.

Authors:  Changmeng Cai; Sen Chen; Patrick Ng; Glenn J Bubley; Peter S Nelson; Elahe A Mostaghel; Brett Marck; Alvin M Matsumoto; Nicholas I Simon; Hongyun Wang; Shaoyong Chen; Steven P Balk
Journal:  Cancer Res       Date:  2011-08-25       Impact factor: 12.701

Review 4.  Mechanisms mediating androgen receptor reactivation after castration.

Authors:  Xin Yuan; Steven P Balk
Journal:  Urol Oncol       Date:  2009 Jan-Feb       Impact factor: 3.498

Review 5.  Androgen receptor functions in castration-resistant prostate cancer and mechanisms of resistance to new agents targeting the androgen axis.

Authors:  X Yuan; C Cai; S Chen; S Chen; Z Yu; S P Balk
Journal:  Oncogene       Date:  2013-06-10       Impact factor: 9.867

6.  Remission of progressive metastatic castration-resistant prostate cancer during abiraterone therapy following unilateral adrenalectomy for a functioning adrenal adenoma.

Authors:  Katelyn Nazaneen Seale; Matthew K Labriola; Xiaoyin Sara Jiang; Andrew Armstrong
Journal:  BMJ Case Rep       Date:  2022-10-05

7.  Response to aminoglutethimide and cortisone acetate in advanced prostatic cancer.

Authors:  B A Ponder; R J Shearer; R D Pocock; J Miller; D Easton; C E Chilvers; M Dowsett; S L Jeffcoate
Journal:  Br J Cancer       Date:  1984-12       Impact factor: 7.640
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.